U.S. FDA advisors recommend approval of Teva asthma drug in adults

(Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended on Wednesday that the agency approve Teva Pharmaceutical Industries Ltd's <TEVA.TA) experimental drug reslizumab for severe asthma in patients aged 18 and older.

http://ift.tt/1M3Innd

from Reuters: Health News
via animenewspro